A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Clinical trial NCT00366379 · COMPLETED

Trial details

NCT number: NCT00366379
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2006-07-01
Primary completion: 2007-06-01
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.